Milroy Disease
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
FLT4,
CELSR1,
VEGFC,
GATA2,
GJC2,
FOXC2,
VEGFA,
TP53,
H3P10,
MYC,
IGH,
VEGFD,
SOX18,
CDKN2A,
CD40,
B2M,
LYVE1,
PERCC1,
PTEN,
RB1,
SFRP1,
SFRP5,
SMUG1,
MAFB,
RASSF1,
CDC42EP1,
CNTRL,
ABCB1,
PIEZO1,
RELN
FLT4,
CELSR1,
VEGFC,
GATA2,
GJC2,
FOXC2,
VEGFA,
TP53,
H3P10,
MYC,
IGH,
VEGFD,
SOX18,
CDKN2A,
CD40,
B2M,
LYVE1,
PERCC1,
PTEN,
RB1,
SFRP1,
SFRP5,
SMUG1,
MAFB,
RASSF1,
CDC42EP1,
CNTRL,
ABCB1,
PIEZO1,
RELN,
AKT1,
NTRK1,
FDXR,
APOE,
FAS,
CCND1,
BCR,
BRAF,
CD27,
CKS1B,
CRP,
FGFR3,
NCAM1,
GJA1,
GNA12,
GRN,
IL6,
IL6R,
KIF11,
AKR1B1,
MDM2,
LIM2
Drugs
—
Registered!
Milroy disease is a frequent form of primary lymphedema (see this term) characterized generally by painless, chronic lower-limb lymphedema found at birth or developing in the early neonatal period.